Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Cefixime 800 mg Plus Doxycycline 100 mg b.i.d. for 7 Days Compared to Ceftriaxone 1 g Plus Azithromycin 2 g for Treatment of Urogenital, Rectal and Pharyngeal Gonorrhoea: A Randomised Controlled Trial

NCT06090565 is registered in ClinicalTrials.gov with Bulovka Hospital as lead sponsor.

NCT NCT06090565
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06090565 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Cefixime 800 mg Plus Doxycycline 100 mg b.i.d. for 7 Days Compared to Ceftriaxone 1 g Plus Azithromycin 2 g for Treatment of Urogenital, Rectal and Pharyngeal Gonorrhoea: A Randomised Controlled Trial
Lead sponsor
Bulovka Hospital
Phase
Phase 4
Overall status
Completed
Start date
April 1, 2021
Completion date
December 22, 2022
Enrollment
161 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

gonorrhea